[Laboratory and clinical studies of cefoxitin in pediatric field (author's transl)].

Author: HiromatsuK, NishimuraT, TabukiK, TakashimaT

Paper Details 
Original Abstract of the Article :
The authors have carried out the laboratory and clinical studies of cefoxitin. The results were as follows: The sensitivity was estimated by plate dilution method on 26 strains of S. aureus, 25 strains of E. coli, 24 strains of K. pneumoniae, 27 strains of Serratia and 17 strains of Salmonella isola...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/7289024

データ提供:米国国立医学図書館(NLM)

Cefoxitin: A Powerful Weapon Against Pediatric Infections

In the realm of pediatric medicine, combating infections is a constant challenge. This study, like a skilled desert physician, examines the efficacy and safety of cefoxitin, an antibiotic, in treating bacterial infections in children. The researchers conducted laboratory and clinical studies to evaluate the antibiotic's effectiveness and its impact on the young patients.

The study found that cefoxitin demonstrated a high level of sensitivity against various bacterial strains, including Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae. In clinical trials, the antibiotic was well-tolerated and effective in treating bacterial infections in children, showing promising results in alleviating symptoms and promoting recovery.

Cefoxitin: A Shield Against Pediatric Infections

This research provides valuable insights into the use of cefoxitin in treating pediatric infections. The study's findings highlight the antibiotic's effectiveness and safety, offering clinicians a powerful tool for combating bacterial infections in young patients. This knowledge is crucial for improving patient outcomes and promoting their well-being.

A Boon for Pediatric Health

This study, like a refreshing spring in the desert, offers a beacon of hope for pediatric health. By providing a safe and effective treatment option for bacterial infections, cefoxitin can help to reduce the suffering and complications associated with these illnesses. It is a testament to the power of scientific innovation in improving the lives of children.

Dr.Camel's Conclusion

Cefoxitin, like a strong camel carrying precious cargo through the desert, demonstrates its ability to combat pediatric infections effectively and safely. This study provides a valuable resource for clinicians, helping them to navigate the challenging landscape of pediatric medicine.

Date :
  1. Date Completed 1981-12-21
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

7289024

DOI: Digital Object Identifier

7289024

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.